Hospice of SC/Agapé Hospice Adopts Muse Predictive Modeling Technology

Spartanburg, SC, June 1, 2020 – Following the announcement of Hospice Care of South Carolina’s (HCSC) acquisition of Agapé Hospice, the company is proud to announce the adoption of MUSE Healthcare’s predictive modeling technology. Using MUSE insights, Hospice Care of South Carolina/Agapé Hospice employees caring for more than 1,400 patients daily are enabled to provide the right care for patients and families when they need it most. The new product uses sophisticated modeling and machine learning to better predict, prepare and provide for hospice patients in the last seven to 12 days of life.

“By adopting a supportive tool like MUSE, we can ensure our patients are receiving enhanced hands-on care in those critical last seven to ten days of life,” said Troy Yarborough, chief executive officer of Hospice Care of South Carolina/Agapé Hospice. “MUSE gives our caregivers additional insights to the patient needs and allows us to quickly identify which patients require focused support. There is no other product in the market that provides this kind of detail and insight.”

For many years, the Centers for Medicare & Medicaid Services (CMS) has been monitoring and publicly reporting certain hospice care data points with a primary mission of promoting the delivery of high-quality hospice services. Recently, CMS updated the way it measures quality for hospice programs to include the frequency of visits at the very end of life with an expectation that quality is demonstrated by an increase in patient visits over the last three and seven days of life.

HCSC/Agapé Hospice has been working diligently to enhance care during this time, consistently providing care above the state average of six visits. “After implementing the MUSE tool, we are now providing ten or more intense visits for our patients. We believe this dedicated deployment of resources demonstrates our commitment to provide the utmost quality care to the patients and families across South Carolina,” said Yarborough.

“Implementation of MUSE and integrating this best in class analytics tool into our existing technology platform was amazingly quick and easy,” said Carry vandenMaagdenberg, HCSC/Agapé Hospice’s chief operating officer. “The MUSE team has done an exemplary job creating a tool so intuitive that it takes minimal time to learn and adopt. The technology does not replace clinical judgment but rather emphasizes clinical findings. It alerts us when a patient would benefit from additional visits to ensure our patients and their families receive the care that matters most in the final days and hours of the patient’s life.”

Jennifer Maxwell, MUSE Healthcare’s president and co-founder said, “We are proud to work closely with the HCSC/Agapé Hospice team on implementing our solution. We believe the MUSE transition product will change hospice care as we know it today. With all of the activity and discussion around improving quality at the bedside, adopting enhanced tools to support the clinical effort will ensure the hospice is prepared for the future.”


Muse Healthcare was founded in 2019 by three leading hospice industry professionals — Jennifer Maxwell, Tom Maxwell, and Bryan Mosher. Their mission is to equip clinicians with world-class analytics to ensure every hospice patient transitions with unparalleled quality and dignity. Muse’s predictive model considers hundreds of thousands of data points from millions of visits to identify which hospice patients are most likely to transition within 7-12 days. The science that powers Muse is considered a true deep learning neural network – the only one of its kind in the hospice space. When hospice care providers can more accurately predict when their patients will transition, they can ensure their patients and their patients’ families receive the care that matters most in the final days and final hours of a patient’s life.

For more information, visit